With nod from panel, Aerie inches toward FDA approval
October 13, 2017 at 17:01 PM EDT
Aerie Pharmaceuticals (Nasdaq: AERI) – which is in the process of building out its research and development team locally – is moving closer to U.S. Food and Drug Administration approval.
